EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 26 / No 4 (Avril 2010) Med Sci (Paris), 26 4 (2010) 385-390 References
Free Access
Issue
Med Sci (Paris)
Volume 26, Number 4, Avril 2010
Page(s) 385 - 390
Section M/S revues
DOI https://doi.org/10.1051/medsci/2010264385
Published online 15 April 2010
  1. Festa A, Williams K, D’Agostino R Jr, et al. The natural course of beta-cell function in nondiabetic and diabetic individuals: the insulin resistance atherosclerosis study. Diabetes 2006; 55 : 1114–20. [Google Scholar]
  2. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest 2006; 116 : 1802–12. [Google Scholar]
  3. Unger RH, Orci L. Lipoapoptosis: its mechanism and its diseases. Biochim Biophys Acta 2002; 1585 : 202–12. [Google Scholar]
  4. Girard J. Rôle des acides gras libres dans la sécrétion et l’action de l’insuline : mécanismes de la lipotoxicité. Med Sci (Paris) 2003; 19 : 827–33. [Google Scholar]
  5. Ishikawa M, Iwasaki Y, Yatoh S, et al. Cholesterol accumulation and diabetes in pancreatic beta-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicity. J Lipid Res 2008; 49 : 2524–34. [Google Scholar]
  6. Hao M, Head WS, Gunawardana SC, et al. Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction. Diabetes 2007; 56 : 2328–38. [Google Scholar]
  7. Brunham LR, Kruit JK, Pape TD, et al. Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med 2007; 13 : 340–7. [Google Scholar]
  8. Efanov AM, Sewing S, Bokvist K, Gromada J. Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic beta-cells. Diabetes 2004; 53 (suppl 3) : S75–8. [Google Scholar]
  9. Gerin I, Dolinsky VW, Shackman JG, et al. LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function. J Biol Chem 2005; 280 : 23024–31. [Google Scholar]
  10. McNeish J, Aiello RJ, Guyot D, et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc Natl Acad Sci USA 2000; 97 : 4245–50. [Google Scholar]
  11. Gerstein HC, Yusuf S, Bosch J, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 2006; 368 : 1096–105. [Google Scholar]
  12. Grupping AY, Cnop M, Van Schravendijk CF, et al. Low density lipoprotein binding and uptake by human and rat islet beta cells. Endocrinology 1997; 138 : 4064–8. [Google Scholar]
  13. Cnop M, Hannaert JC, Grupping AY, Pipeleers DG. Low density lipoprotein can cause death of islet beta-cells by its cellular uptake and oxidative modification. Endocrinology 2002; 143 : 3449–53. [Google Scholar]
  14. Roehrich ME, Mooser V, Lenain V, et al. Insulin-secreting beta-cell dysfunction induced by human lipoproteins. J Biol Chem 2003; 278 : 18368–75. [Google Scholar]
  15. Abderrahmani A, Niederhauser G, Favre D, et al. Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells. Diabetologia 2007; 50 : 1304–14. [Google Scholar]
  16. Okajima F, Kurihara M, Ono C, et al. Oxidized but not acetylated low-density lipoprotein reduces preproinsulin mRNA expression and secretion of insulin from HIT-T15 cells. Biochim Biophys Acta 2005; 1687 : 173–80. [Google Scholar]
  17. Rutti S, Ehses JA, Sibler RA, et al. Low and high-density lipoproteins modulate function, apoptosis and proliferation of primary human and murine pancreatic beta cells. Endocrinology 2009; 150 : 4521–30 [Google Scholar]
  18. Salaun C, James DJ, Chamberlain LH. Lipid rafts and the regulation of exocytosis. Traffic 2004; 5 : 255–64. [Google Scholar]
  19. Lang T. SNARE proteins and “membrane rafts”. J Physiol 2007; 585 : 693–8. [Google Scholar]
  20. Xia F, Gao X, Kwan E, et al. Disruption of pancreatic beta-cell lipid rafts modifies Kv2.1 channel gating and insulin exocytosis. J Biol Chem 2004; 279 : 24685–91. [Google Scholar]
  21. Ohara-Imaizumi M, Nishiwaki C, Kikuta T, et al. Site of docking and fusion of insulin secretory granules in live MIN6 beta cells analyzed by TAT-conjugated anti-syntaxin 1 antibody and total internal reflection fluorescence microscopy. J Biol Chem 2004; 279 : 8403–8. [Google Scholar]
  22. Takahashi N, Hatakeyama H, Okado H, et al. Sequential exocytosis of insulin granules is associated with redistribution of SNAP25. J Cell Biol 2004; 165 : 255–62. [Google Scholar]
  23. Vikman J, Jimenez-Feltstrom J, Nyman P, et al. Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol. FASEB J 2009; 23 : 58–67. [Google Scholar]
  24. Xia F, Xie L, Mihic A, Gao X, et al. Inhibition of cholesterol biosynthesis impairs insulin secretion and voltage-gated calcium channel function in pancreatic beta-cells. Endocrinology 2008; 149 : 5136–45. [Google Scholar]
  25. Freeman DJ, Norrie J, Sattar N, et al. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland coronary prevention study. Circulation 2001; 103 : 357–62. [Google Scholar]
  26. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 20 ; 359 : 2195–207. [Google Scholar]
  27. Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 2010; 375 : 735–42. [Google Scholar]
  28. Ishikawa M, Okajima F, Inoue N, et al. Distinct effects of pravastatin, atorvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells. J Atheroscler Thromb 2006; 13 : 329–35. [Google Scholar]
  29. Metz SA, Rabaglia ME, Stock JB, Kowluru A. Modulation of insulin secretion from normal rat islets by inhibitors of the post-translational modifications of GTP-binding proteins. Biochem J 1993; 295 : 31–40. [Google Scholar]
  30. Yada T, Nakata M, Shiraishi T, Kakei M. Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet beta-cells. Br J Pharmacol 1999; 126 : 1205–13. [Google Scholar]
  31. Brunham LR, Kruit JK, Verchere CB, Hayden MR. Cholesterol in islet dysfunction and type 2 diabetes. J Clin Invest 2008; 118 : 403–8. [Google Scholar]
  32. Schaefer EJ, Brousseau ME, Diffenderfer MR, et al. Cholesterol and apolipoprotein B metabolism in Tangier disease. Atherosclerosis 2001; 159 : 231–6. [Google Scholar]
  33. Villarreal-Molina MT, Guilar-Salinas CA, Rodriguez-Cruz M, et al. The ATP-binding cassette transporter A1 R230C variant affects HDL cholesterol levels and BMI in the Mexican population: association with obesity and obesity-related comorbidities. Diabetes 2007; 56 : 1881–7. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.